Author(s): Ledford DK, Espinoza LR
Abstract Share this page
Abstract The current classification scheme of the diverse inflammatory cardiovascular diseases permits a clinical staging and facilitates prognostic assessment and therapeutic decision making. Ultimately, improvement in the classification of and definitive therapy for these conditions awaits better definition of the interaction among specific etiologic agents, host factors, and the immune system responsible for these diseases.
This article was published in JAMA
and referenced in Journal of Cancer Clinical Trials